Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide )

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Rights to the proprietary formulation of a medical product. It consists of proprietary formulation of budesonide for the treatment of various inflammatory and allergic conditions of the eye. Budesonide is provided for the treatment of asthma.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Acquirer
Primary Office
  • Italy

Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide ) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide )‘s full profile, request access.

Request full access to PitchBook

Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide ) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide )‘s full profile, request access.

Request full access to PitchBook